February 2024 Archive
TollereBio Advancing Vaccine Adjuvant Platform with Novel Technology Licensed from University of Maryland, Baltimore
Monday, February 12, 2024
The University of Maryland, Baltimore spin-out is commercializing technology invented by Robert K. Ernst, PhD, a faculty researcher and entrepreneur at the University of Maryland School of Dentistry. BALTIMORE, Maryland, February 12, 2024 – TollereBio, a Maryland-based biotechnology startup, has... read more